Sustained-release form of basic fibroblast growth factor prevents catheter-related bacterial invasion in mice

Interactive Cardiovascular and Thoracic Surgery

Volumn 4, Issue 6, 2005, Pages 526-530

  Hirose, Keiichi ^a   Marui, Akira ^a   Arai, Yoshio ^a   Fujita, Masatoshi ^a   Nomura, Takamasa ^a   Mitsuyama, Masao ^a   Tabata, Yasuhiko ^b   Komeda, Masashi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Catheter related infection; Growth factor; Sustained release form of bFGF; Tissue regeneration

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN; DACRON; GELATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CATHETER INFECTION; CONTROLLED STUDY; DRUG IMPLANTATION; GRANULATION TISSUE; HISTOLOGY; INFECTION PREVENTION; INOCULATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURGICAL WOUND; SUSTAINED DRUG RELEASE; TISSUE; TISSUE REGENERATION; VESSEL;

EID: 28544442366     PISSN: 15699293     EISSN: 15699293     Source Type: Journal    
DOI: 10.1510/icvts.2005.114926     Document Type: Article

References (12)

1. Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, Valles J. Evaluation of outcome of intravenous catheter-related infection in critically ill patients. Am J Respir Crit Care Med 2000;162:1027-1030.
2. Poston RS, Husain S, Sorce D, Stanford E, Kusne S, Wagener M, Griffith BP, Kormos RL. LVAD Bloodstream infections; therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant 2004;22:914-921.
3. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000;132:391-402.
4. YanagisawaMiwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C. Salvage of infracted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992;257:1401-1403.
5. Rafkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989;109:1-16.
6. Iwakura A, Tabata Y, Miyao M, Ozeki M, Tamura N, Ikai A, Nishimura K, Nakamura T, Shimizu Y, Fujita M, Komeda M. Novel methods to enhance sternal healing after harvesting bilateral internal thoracic arteries with use of basic fibloblast growth factor. Circulation 2000;102(Suppl III)III-307-311.
7. Yamamoto T, Suto N, Okubo T, Mikuniya A, Hanada H, Yagihashi S, Fujita M, Okumura K. Intramyocardial delivery of basic fibloblast growth factor-impregnated gelatin hydrogel microspheres enhances collateral circulation to infracted canine myocardium. Jpn Circ J 2001;65:439-444.
8. Sakakibara Y, Nishimura K, Tambara K, Yamamoto M, Lu F, Tabata Y, Komeda M. Prevascularization with gelatin microspheres containing basic fibloblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 2002;124:50-56.
9. Ueyama K, Bing G, Tabata Y, Ozeki M, Doi K, Nishimura K, Suma H, Komeda M. Development of biologic coronary artery bypass grafting in a rabit model: revival of a classic concept with modern biotechnology. J Thorac Cardiovasc Surg 2004;127:1608-1615.
10. Tabata Y, Nagano A, Ikada Y. Biodegradation of hydrogel carrier incorporating fibloblast growth factor. Tissue Eng 1999;5:127-138.
11. Ferretti G, Mandala M, Di Cosimo S, Moro C, Curigliano G, Barni S. Catheter-related bloodstream infections, part II: specific pathogens and prevention. Cancer Control 2003;10:79-91.
12. Jarvik R, Westaby S, Katsumata T, Pigott D, Evans RD. LVAD power delivery: a percutaneous approach to avoid infection. Ann Thorac Surg 1998;65:470-473.